TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2025
Voltar para busca
Dado oficial do USPTO
ELLUME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
13/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 42
Data de depósito
28/04/2021
Data de registro
01/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/11/2022
Última transação
13/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
AU
Examinador
SALES, HEATHER
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "ELLUME" in black to the right of three gold ovals with a gold circle in the middle.
Titulares e representantes
Titulares
Ellume Limited
Representantes
Michael A. Bondi Moss & Barnett
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of influenzacoronavirus and infectious diseases; medicinal preparations for the treatment of influenzacoronavirus and infectious diseases; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical analysers for medical usemedical diagnostic reagentsassayssolutions and buffers for testing and analysis of blood or bodily fluids for use in disease detection; chemical products for immunoassay useimmunoassay reagents for medical use; immunoassay reagents for medical use
Classe 9
Computer hardware and downloadable computer software for medical purposes in the nature of medical diagnostic testing; Computer hardware and downloadable computer software for medical screeningtestingdiagnosistreatment and reporting; computer hardware being a hand-held digital device for medical diagnostic testinga handheld computer; computer hardware being a hand-held digital device for diagnosing influenzacoronavirus and other infectious diseasesa handheld computer; downloadable application software for use with medical tests for diagnosing influenzacoronavirus and other infectious diseases; readersdata processing equipment; optical readers
Classe 10
Medical apparatusmedical diagnostic apparatus for testing of blood or bodily fluids for use in infectious disease detection; medical apparatusmedical diagnostic apparatus for testing of blood or bodily fluids for the detection of antibodies; diagnostic medical apparatus for testing for infectious diseases; analysers for medical usemedical instruments for detecting and analysing virus in the body; analysers for virus identification for medical purposesmedical instruments for detecting and analysing virus in the body; medical assay apparatusmedical diagnostic apparatus for detection of infectious diseases; diagnostic test kits consisting primarily of probesbuffers and reagents for testing and analysis of blood or bodily fluids for the detection of infectious diseases
Classe 42
Design and development of medical diagnostic products; design and development of medical diagnostic products for the diagnosis of infectious diseases; providing temporary use of non-downloadable web-based software for medical screeningtestingdiagnosistreatment and reporting of results; provision of online non-downloadable software for use with medical tests for diagnosing infectious diseases; provision of online non-downloadable software for use with medical tests for diagnosing influenzacoronavirus and other infectious diseases; provision of online non-downloadable computer software for medical screeningtestingdiagnosistreatment and reporting of results
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/04/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/02/2023
FIMP
FINAL DISPOSITION PROCESSED
22/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
23/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/08/2022
PUBO
PUBLISHED FOR OPPOSITION
16/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
30/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
30/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/06/2022
RFNT
REFUSAL PROCESSED BY IB
15/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/12/2021
RFRR
REFUSAL PROCESSED BY MPU
27/12/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/12/2021
CNRT
NON-FINAL ACTION WRITTEN
01/12/2021
DOCK
ASSIGNED TO EXAMINER
30/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
15/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELLUME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.